These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 6259605

  • 1. [Cefotaxime treatment of 25 cases of severe enterobacteriaceae infections in an intensive care unit (author's transl)].
    Motin J, Bouletreau P, Auboyer C, Bui-Xuan B, Flandrois JP, Reverdy ME.
    Nouv Presse Med; 1981 Feb 26; 10(8):617-21. PubMed ID: 6259605
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Cefotaxime in digestive tract infections (author's transl)].
    Paris J, Paris JC, Gérard A.
    Nouv Presse Med; 1981 Feb 26; 10(8):647-9. PubMed ID: 6259611
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)].
    Aufrant C, Lambert-Zechovsky N, Aujard Y, Bingen E, Blum C, Beaufils F, Mathieu H.
    Nouv Presse Med; 1981 Feb 26; 10(8):639-46. PubMed ID: 6259610
    [Abstract] [Full Text] [Related]

  • 7. [Cefotaxime in bronchopulmonary infections (author's transl)].
    Kermarec J, Sauvaget J.
    Nouv Presse Med; 1981 Feb 26; 10(8):650-3. PubMed ID: 6259612
    [Abstract] [Full Text] [Related]

  • 8. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB, Canton P, Roche G, Weber M, Gérard A.
    Nouv Presse Med; 1981 Feb 26; 10(8):601-6. PubMed ID: 6259602
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM, Giraud F.
    Nouv Presse Med; 1981 Feb 26; 10(8):629-33. PubMed ID: 6259608
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cephalexin monohydrate in infections of the soft and superficial tissues].
    Mendez Hernandez D, Mendoza Hernandez P, Diaz Muñoz A, Chavez Max G.
    Prensa Med Mex; 1970 Feb 26; ():27-31. PubMed ID: 5517244
    [No Abstract] [Full Text] [Related]

  • 15. The newest cephalosporins: how to use them?
    Ehrenkranz NJ, Hoffman TA.
    J Fla Med Assoc; 1982 Oct 26; 69(10):863-4. PubMed ID: 6292322
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [In-vitro activity of cefotaxime].
    Knothe H.
    Wien Klin Wochenschr Suppl; 1983 Oct 26; 142():4-7. PubMed ID: 6316671
    [Abstract] [Full Text] [Related]

  • 19. [Concentrations of cefotaxime in human tissues and fluids. A review of published data (author's transl)].
    Galy J, Mantel O.
    Nouv Presse Med; 1981 Feb 26; 10(8):565-73. PubMed ID: 6259594
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.